Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 43.85M P/E - EPS this Y - Ern Qtrly Grth -
Income -34.63M Forward P/E -0.75 EPS next Y - 50D Avg Chg -18.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 23.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -64.00%
Recommedations 1.00 Quick Ratio 0.99 Shares Outstanding 4.70M 52W Low Chg 110.00%
Insider Own 2.91% ROA -83.33% Shares Float 4.23M Beta 0.62
Inst Own 21.73% ROE - Shares Shorted/Prior 91.62K/110.66K Price 0.71
Gross Margin - Profit Margin - Avg. Volume 2,247,787 Target Price 10.00
Oper. Margin - Earnings Date Oct 2 Volume 695,066 Change -4.20%
About eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E; and collaboration agreement with the Dana-Farber Cancer Institute on a Phase 2 clinical trial, evaluating Zotatifin as combination treatment in ER+ endometrial cancer and in low grade serous ovarian cancer. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.

eFFECTOR Therapeutics, Inc. News
06/24/24 eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq
05/20/24 eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
05/09/24 eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
04/09/24 eFFECTOR Therapeutics to Participate in Upcoming Investor Conference
04/04/24 eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer
03/25/24 eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
02/05/24 eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
01/29/24 eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
01/25/24 eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
01/09/24 eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024
01/09/24 eFFECTOR Therapeutics Announces Reverse Stock Split
12/08/23 eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients
11/28/23 eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin in Combination with Fulvestrant and Abemaciclib for Treatment of ER+/HER2- Advanced Metastatic Breast Cancer
EFTR Chatroom

User Image Bullishbruk Posted - 2 weeks ago

@Wallst45 be careful with this guy pump and dump is his game remember $EFTR $XFOR $PDSB to name a few

User Image zawojak Posted - 2 weeks ago

$UNCY So in the next two weeks, either positive news and stock goes over $1 and stays there, or bad news then possibly it will drop to $0.30 and Mr Gupta will ask NASDAQ for extension or Mr Gupta will kick off RS split and we are all cooked and loosers bag holders. 3:1 chances of making money here. I am bullish but was bullish with $EFTR and lost 90%. πŸ’©

User Image zawojak Posted - 10/23/24

$SLS I can sense another $EFTR here guys, be careful πŸ“‰

User Image Stocksrunner Posted - 1 month ago

Tough day for these stocks... $THMO, $GROM, $EFTR, $AWIN, $IONM all taking a hit and dropping hard. πŸ“‰ Let's see if they can bounce back from this.

User Image Stocksrunner Posted - 1 month ago

Tough day for these stocks... πŸ“‰ Here are today's top losers: $EFTR $IDEX $DRUG $WAVE $DBGI 😬 Hope for a bounce back, but the road looks rough ahead. https://stocksrunner.com/home

User Image Stocksrunner Posted - 1 month ago

Rough day for these stocks... πŸ“‰πŸ˜” $UAVS $SEEL $THMO $BNL $EFTR taking a beating. Tough market conditions hitting hard. Stay cautious, traders.

User Image NextNeighbour Posted - 1 month ago

$EFTR what’s happening with this stock.Whats news? Anyone can you pls share?

User Image Capitulation_0 Posted - 1 month ago

$EFTR Sad to see this one die. CEO not too long ago said he has never seen the excitement around his compound in 20 years. He came from big pharma and I suspect people believed him and didn't think he was some sort of snake oil salesman.

User Image Manipulation13F Posted - 09/29/24

$EFTR I love comming around when things get spicy πŸ‘€

User Image zawojak Posted - 2 months ago

$UNCY Seems like I made mistake again, stock reminds me of $EFTR. Management may announce something shitty soon and we will get $0.03 SP. It just doesn't sound right. CEO doesn't keep shareholders updated with anything. BTW when should we expect NDA to be approved? Are there any upcoming catalysts ???

User Image zawojak Posted - 3 months ago

@Letsinvest2024 This quietness worries me, $EFTR was same quiet before wind up ans stock dropped 95%

User Image zawojak Posted - 07/31/24

@AS1980 look at $eftr same story

User Image lqqkerinsiderDOTcom Posted - 07/30/24

@pmcd777 Apparently, $EFTR is bottomless. Might go negative soon at this rate!

User Image zawojak Posted - 07/30/24

$SLS Don't be $EFTR

User Image zawojak Posted - 07/30/24

$ATXI may follow $EFTR :\

User Image Fearless_Contrarian Posted - 07/29/24

$EFTR I’m down 99% on this. But, I can I lose, if I don’t sell πŸ˜‚ ? Thankfully it is tiny portion of my portfolio.

User Image zawojak Posted - 07/29/24

$ATXI May go to administration like $EFTR

User Image Fearless_Contrarian Posted - 07/26/24

$EFTR This is the worst speculative stock investment I ever made. I’m down 99% πŸ˜‚ Thankfully , it was tiny % of my portfolio

User Image Kikic Posted - 07/25/24

$EFTR ops πŸ€™

User Image chrisnyc578 Posted - 07/23/24

$EFTR what will happen to assets? Buy out still possible?

User Image Stocksrunner Posted - 4 months ago

😞 The top losers of the day have taken a significant hit. πŸ“‰ Here are the stocks that struggled: $ASLN $KZIA $NAAS $GETR $EFTR. Let's hope for a better tomorrow.

User Image zawojak Posted - 4 months ago

$SLS behaves like $EFTR before "the news ...:/

User Image newsfile_corp Posted - 4 months ago

https://nfne.ws/216456 $EFTR #Banking #FinancialServices #NASDAQ #Investing

User Image EddieH2020 Posted - 4 months ago

$EFTR Management team should be in prison

User Image Dustinash Posted - 4 months ago

$EFTR were up over 100% from all time low which happened this week. This stock isn’t in bankruptcy. They are OTC. These shares could easily move up over a dollar with certain events. My guess is that it is being prepared as a buy out. Keep in mind $PFE had a 500 million dollar potential pipeline with $EFTR. It’s really unclear how much progress or potential remains there. But if they decide to nab its tech, even at 10 million plus paying off debt that would position share prices at 70x what they are now.

User Image SumWiiTodd Posted - 4 months ago

$EFTR did this get delisted?

User Image Stocksrunner Posted - 4 months ago

πŸš€ Thursday's Top GainersπŸ”₯ Wow! What a day for these stocks! Check out today's biggest winners: $CYN $KZIA $EFTR $NEXI $BDRX These tickers were on fire! πŸ”₯

User Image Stocksrunner Posted - 4 months ago

Wednesday's Wipeout: πŸ“‰ Looks like the bulls went on a lunch break and forgot to come back. These were the worst performers today, and let's just say it's not pretty. $ZAPP $SISI $CVRX $ICU $EFTR Prepare for more pain tomorrow, folks. This ain't over yet.

User Image zawojak Posted - 4 months ago

$SLS If data is soooo promising why there is such a small interest in this stock ?? all it does is tanking on any news. Why would investor hold it ? Smells like $EFTR to me tbh.

User Image Golibajje Posted - 4 months ago

$EFTR Lawsuit is the only option if you get something out of this!! imo.. CEO was involved with Oxford on well orchestrated scam! they ensured cash going below loan and Oxford triggered default on the company.. which means they will be in possession of company assets! shareholders would get nothing!! Read this:

Analyst Ratings
HC Wainwright & Co. Buy Mar 28, 24
HC Wainwright & Co. Buy Feb 6, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner Nov 27 Sell 0.61 609,163 371,589 1,821,415 11/29/23
WORLAND STEPHEN T Chief Executive Offi.. Chief Executive Officer Aug 11 Option 0.52 33,799 17,575 261,225 08/14/23
Ehrlich Christopher B Director Director Oct 04 Buy 0.57 346 197 35,213 10/06/22
Ehrlich Christopher B Director Director Sep 26 Buy 0.55 18,867 10,377 34,867 09/27/22
Presidio Management Group X LL... 10% Owner 10% Owner Aug 01 Sell 0.8 114,280 91,424 127,569 08/03/22
Presidio Management Group X LL... 10% Owner 10% Owner Jul 28 Sell 0.89 32,517 28,940 131,025 07/29/22
Presidio Management Group X LL... 10% Owner 10% Owner Jul 25 Sell 0.91 48,719 44,334 132,009 07/27/22
Presidio Management Group X LL... 10% Owner 10% Owner Jul 20 Sell 0.96 20,309 19,497 133,483 07/22/22
Gallagher Brian M. Jr. Director Director Jun 23 Buy 1.59 30,000 47,700 30,000 06/27/22
WORLAND STEPHEN T President and Chief.. President and Chief Executive Jun 07 Buy 1.37 20,000 27,400 214,978 06/09/22
Byrnes Michael Chief Financial Offi.. Chief Financial Officer Jun 07 Buy 1.3305 25,000 33,262 29,233 06/07/22
Presidio Management Group X LL... 10% Owner 10% Owner May 17 Sell 1.72 34,427 59,214 136,241 05/19/22
Presidio Management Group X LL... 10% Owner 10% Owner May 12 Sell 1.86 46,176 85,887 137,309 05/16/22
Presidio Management Group X LL... 10% Owner 10% Owner May 09 Sell 2.43 48,984 119,031 138,741 05/11/22
Ehrlich Christopher B Director Director Feb 08 Buy 4.84 2,000 9,680 13,000 02/10/22
Ehrlich Christopher B Director Director Feb 03 Buy 5.08 6,000 30,480 11,000 02/07/22
Ehrlich Christopher B Director Director Jan 27 Buy 5.303 5,000 26,515 5,000 01/31/22
ROOT JONATHAN D Director Director Dec 02 Sell 5.68 8,113 46,082 140,261 12/06/21
Presidio Management Group X LL... 10% Owner 10% Owner Dec 02 Sell 5.68 8,113 46,082 140,261 12/06/21
Presidio Management Group X LL... 10% Owner 10% Owner Nov 29 Sell 6.55 72,418 474,338 140,513 12/01/21
ROOT JONATHAN D Director Director Nov 29 Sell 6.55 72,418 474,338 140,513 12/01/21
ROOT JONATHAN D Director Director Nov 15 Sell 9.45 23,625 223,256 146,063 11/17/21
Presidio Management Group X LL... 10% Owner 10% Owner Nov 15 Sell 9.45 23,625 223,256 146,063 11/17/21
ROOT JONATHAN D Director Director Nov 09 Sell 10.47 86,802 908,817 146,794 11/12/21
Presidio Management Group X LL... 10% Owner 10% Owner Nov 09 Sell 10.47 86,802 908,817 146,794 11/12/21